Growth Metrics

Biocryst Pharmaceuticals (BCRX) Accounts Payables: 2010-2014

Historic Accounts Payables for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $2.8 million.

  • Biocryst Pharmaceuticals' Accounts Payables rose 66.90% to $3.8 million in Q3 2015 from the same period last year, while for Sep 2015 it was $3.8 million, marking a year-over-year increase of 66.90%. This contributed to the annual value of $2.8 million for FY2014, which is 31.74% down from last year.
  • According to the latest figures from FY2014, Biocryst Pharmaceuticals' Accounts Payables is $2.8 million, which was down 31.74% from $4.2 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Accounts Payables registered a high of $8.2 million during FY2010, and its lowest value of $2.5 million during FY2011.
  • For the 3-year period, Biocryst Pharmaceuticals' Accounts Payables averaged around $3.7 million, with its median value being $4.0 million (2012).
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Accounts Payables plummeted by 69.55% in 2011, and later soared by 59.15% in 2012.
  • Over the past 5 years, Biocryst Pharmaceuticals' Accounts Payables (Yearly) stood at $8.2 million in 2010, then crashed by 69.55% to $2.5 million in 2011, then soared by 59.15% to $4.0 million in 2012, then climbed by 5.03% to $4.2 million in 2013, then tumbled by 31.74% to $2.8 million in 2014.